Title |
Potential drug interactions and duplicate prescriptions among ambulatory cancer patients: a prevalence study using an advanced screening method
|
---|---|
Published in |
BMC Cancer, December 2010
|
DOI | 10.1186/1471-2407-10-679 |
Pubmed ID | |
Authors |
Roelof WF van Leeuwen, Eleonora L Swart, Frits A Boom, Martin S Schuitenmaker, Jacqueline G Hugtenburg |
Abstract |
The pharmacotherapeutic treatment of patients with cancer is generally associated with multiple side-effects. Drug interactions and duplicate prescriptions between anti-cancer drugs or interactions with medication to treat comorbidity can reinforce or intensify side-effects.The aim of the present study is to gain more insight into the prevalence of drug interactions and duplicate prescriptions among patients being treated in the outpatient day care departments for oncology and hematological illnesses. For the first time the prevalence of drug interactions with OTC-drugs in cancer patients will be studied. Possible risk factors for the occurrence of these drug-related problems will also be studied. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 65 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 8 | 12% |
Researcher | 7 | 11% |
Student > Ph. D. Student | 7 | 11% |
Student > Doctoral Student | 7 | 11% |
Student > Bachelor | 7 | 11% |
Other | 13 | 20% |
Unknown | 16 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 18 | 28% |
Pharmacology, Toxicology and Pharmaceutical Science | 16 | 25% |
Nursing and Health Professions | 6 | 9% |
Agricultural and Biological Sciences | 1 | 2% |
Physics and Astronomy | 1 | 2% |
Other | 6 | 9% |
Unknown | 17 | 26% |